Gardiner Elizabeth E, Andrews Robert K
Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Transfus Med Rev. 2014 Apr;28(2):56-60. doi: 10.1016/j.tmrv.2014.03.001. Epub 2014 Mar 12.
Quantity, quality, and lifespan are 3 important factors in the physiology, pathology, and transfusion of human blood platelets. The aim of this review is to discuss the proteolytic regulation of key platelet-specific receptors, glycoprotein(GP)Ib and GPVI, involved in the function of platelets in hemostasis and thrombosis, and nonimmune or immune thrombocytopenia. The scope of the review encompasses the basic science of platelet receptor shedding, practical aspects related to laboratory analysis of platelet receptor expression/shedding, and clinical implications of using the proteolytic fragments as platelet-specific biomarkers in vivo in terms of platelet function and clearance. These topics can be relevant to platelet transfusion regarding both changes in platelet receptor expression occurring ex vivo during platelet storage and/or clinical use of platelets for transfusion. In this regard, quantitative analysis of platelet receptor profiles on blood samples from individuals could ultimately enable stratification of bleeding risk, discrimination between causes of thrombocytopenia due to impaired production vs enhanced clearance, and monitoring of response to treatment prior to change in platelet count.
数量、质量和寿命是人类血小板生理学、病理学及输血过程中的三个重要因素。本综述旨在探讨关键血小板特异性受体糖蛋白(GP)Ib和GPVI的蛋白水解调节,这两种受体参与血小板在止血和血栓形成以及非免疫性或免疫性血小板减少症中的功能。综述范围涵盖血小板受体脱落的基础科学、与血小板受体表达/脱落实验室分析相关的实际方面,以及在体内将蛋白水解片段用作血小板特异性生物标志物对血小板功能和清除的临床意义。这些主题可能与血小板输血相关,包括血小板储存过程中体外发生的血小板受体表达变化和/或临床输血用血小板。在这方面,对个体血样中血小板受体谱进行定量分析最终可实现出血风险分层、区分血小板生成受损与清除增强导致的血小板减少症病因,以及在血小板计数改变之前监测治疗反应。